Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AAN 2023 | Issues with essential tremor therapies

Chantale Branson • 27 Apr 2023
AAN 2023
Movement Disorders

Chantale Branson, MD, Morehouse School of Medicine, Atlanta, GA, discusses current difficulties in treating essential tremor. The pathomechanism of essential tremor is not one disease, which makes it more difficult to treat. Potential therapies include T-type calcium channel inhibitors, which have not yet been validated in humans, and MRI-guided FUS. This interview took place at the American Academy of Neurology Annual Meeting 2023 in Boston, MA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Chantale Branson

PURE: a program for non-motor PD symptoms
2:25
PURE: a program for non-motor PD symptoms
Chantale Branson • 27 Apr 2023
Update on current therapies for essential tremor
4:35
Update on current therapies for essential tremor
Chantale Branson • 27 Apr 2023
Dystonia: recent developments
1:45
Dystonia: recent developments
Chantale Branson • 27 Apr 2023
Hypersomnia management in MS and Parkinson’s disease
2:18
Hypersomnia management in MS and Parkinson’s disease
Chantale Branson • 7 Apr 2021

Related Videos

Current treatment and unmet needs in neurologic Wilson's disease
3:15
Current treatment and unmet needs in neurologic Wilson's disease
Aurelia Poujois • 29 Jun 2026
Findings from the Phase III FoCus trial: tiomolibdate choline for neurologic Wilson's disease
3:18
Findings from the Phase III FoCus trial: tiomolibdate choline for neurologic Wilson's disease
Aurelia Poujois • 29 Jun 2026
Emerging therapies for neurologic Wilson's disease
2:42
Emerging therapies for neurologic Wilson's disease
Aurelia Poujois • 29 Jun 2026
Indicators of advanced-stage Parkinson’s disease
2:30
Indicators of advanced-stage Parkinson’s disease
K. Ray Chaudhuri • 30 Jun 2026

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJNeurology is intended for healthcare professionals